Hawaïen autochtone ou autre insulaire du Pacifique : Questions médicales fréquentes
Nom anglais: Native Hawaiian or Other Pacific Islander
Descriptor UI:D044468
Tree Number:M01.686.493.500.800.500
Termes MeSH sélectionnés :
Cognitive Dysfunction
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hawaïen autochtone ou autre insulaire du Pacifique : Questions médicales les plus fréquentes",
"headline": "Hawaïen autochtone ou autre insulaire du Pacifique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hawaïen autochtone ou autre insulaire du Pacifique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-09",
"dateModified": "2025-04-04",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hawaïen autochtone ou autre insulaire du Pacifique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Population originaire des îles du Pacifique",
"url": "https://questionsmedicales.fr/mesh/D000095188",
"about": {
"@type": "MedicalCondition",
"name": "Population originaire des îles du Pacifique",
"code": {
"@type": "MedicalCode",
"code": "D000095188",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "M01.686.493.500.800"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Hawaïen autochtone ou autre insulaire du Pacifique",
"alternateName": "Native Hawaiian or Other Pacific Islander",
"code": {
"@type": "MedicalCode",
"code": "D044468",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Pearl A McElfish",
"url": "https://questionsmedicales.fr/author/Pearl%20A%20McElfish",
"affiliation": {
"@type": "Organization",
"name": "College of Medicine, University of Arkansas for Medical Sciences Northwest, 2708 S. 48th St, Springdale, AR, 72762, USA. pamcelfish@uams.edu."
}
},
{
"@type": "Person",
"name": "Marie-Rachelle Narcisse",
"url": "https://questionsmedicales.fr/author/Marie-Rachelle%20Narcisse",
"affiliation": {
"@type": "Organization",
"name": "Office of Community Health and Research, University of Arkansas for Medical Sciences, 1125 N. College Ave, Fayetteville, AR 72703, USA."
}
},
{
"@type": "Person",
"name": "Joseph Keawe'aimoku Kaholokula",
"url": "https://questionsmedicales.fr/author/Joseph%20Keawe%27aimoku%20Kaholokula",
"affiliation": {
"@type": "Organization",
"name": "Department of Native Hawaiian Health, John A. Burns School of Medicine, University of Hawai'i at Manoa, 651 Ilalo St, Honolulu, HI, 96813, USA."
}
},
{
"@type": "Person",
"name": "Eunjung Lim",
"url": "https://questionsmedicales.fr/author/Eunjung%20Lim",
"affiliation": {
"@type": "Organization",
"name": "Department of Quantitative Health Sciences, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, HI (JD, EL, JC)."
}
},
{
"@type": "Person",
"name": "Brett Rowland",
"url": "https://questionsmedicales.fr/author/Brett%20Rowland",
"affiliation": {
"@type": "Organization",
"name": "Office of Community Health and Research, University of Arkansas for Medical Sciences Northwest, 2708 S. 48th St, Springdale, AR, 72762, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Predictors of cognitive dysfunction in hereditary transthyretin amyloidosis with liver transplant.",
"datePublished": "2022-10-17",
"url": "https://questionsmedicales.fr/article/36251860",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/13506129.2022.2131384"
}
},
{
"@type": "ScholarlyArticle",
"name": "Risk factors for cognitive dysfunction amongst patients with cardiovascular diseases.",
"datePublished": "2024-09-13",
"url": "https://questionsmedicales.fr/article/39346594",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fpubh.2024.1385089"
}
},
{
"@type": "ScholarlyArticle",
"name": "Reward network dysfunction is associated with cognitive impairment after stroke.",
"datePublished": "2023-05-31",
"url": "https://questionsmedicales.fr/article/37307650",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.nicl.2023.103446"
}
},
{
"@type": "ScholarlyArticle",
"name": "Predictors of cognitive dysfunction one-year post COVID-19.",
"datePublished": "2023-01-05",
"url": "https://questionsmedicales.fr/article/36603126",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1037/neu0000876"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cognitive Dysfunction Biomarkers in Patients With Rheumatoid Arthritis: A Systematic Review.",
"datePublished": "2022-12-07",
"url": "https://questionsmedicales.fr/article/36729842",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/RHU.0000000000001888"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Personnes",
"item": "https://questionsmedicales.fr/mesh/D009272"
},
{
"@type": "ListItem",
"position": 3,
"name": "Populations d'Océanie",
"item": "https://questionsmedicales.fr/mesh/D000094862"
},
{
"@type": "ListItem",
"position": 4,
"name": "Populations d'Australasie",
"item": "https://questionsmedicales.fr/mesh/D000094861"
},
{
"@type": "ListItem",
"position": 5,
"name": "Population originaire des îles du Pacifique",
"item": "https://questionsmedicales.fr/mesh/D000095188"
},
{
"@type": "ListItem",
"position": 6,
"name": "Hawaïen autochtone ou autre insulaire du Pacifique",
"item": "https://questionsmedicales.fr/mesh/D044468"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hawaïen autochtone ou autre insulaire du Pacifique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hawaïen autochtone ou autre insulaire du Pacifique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hawaïen autochtone ou autre insulaire du Pacifique",
"description": "Comment diagnostiquer une maladie chez les Hawaïens autochtones ?\nQuels tests sont recommandés pour les insulaires du Pacifique ?\nY a-t-il des particularités dans le diagnostic ?\nComment évaluer les risques de maladies spécifiques ?\nLes maladies génétiques sont-elles plus fréquentes ?",
"url": "https://questionsmedicales.fr/mesh/D044468?mesh_terms=Cognitive+Dysfunction&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hawaïen autochtone ou autre insulaire du Pacifique",
"description": "Quels symptômes sont courants chez les Hawaïens autochtones ?\nComment les symptômes diffèrent-ils selon les îles ?\nY a-t-il des symptômes spécifiques aux maladies tropicales ?\nLes symptômes psychologiques sont-ils fréquents ?\nComment les symptômes sont-ils perçus culturellement ?",
"url": "https://questionsmedicales.fr/mesh/D044468?mesh_terms=Cognitive+Dysfunction&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hawaïen autochtone ou autre insulaire du Pacifique",
"description": "Quelles sont les stratégies de prévention pour ces populations ?\nComment promouvoir un mode de vie sain ?\nY a-t-il des campagnes de vaccination spécifiques ?\nComment réduire les risques de maladies chroniques ?\nQuel rôle joue l'éducation communautaire ?",
"url": "https://questionsmedicales.fr/mesh/D044468?mesh_terms=Cognitive+Dysfunction&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hawaïen autochtone ou autre insulaire du Pacifique",
"description": "Quels traitements sont adaptés aux Hawaïens autochtones ?\nY a-t-il des remèdes traditionnels utilisés ?\nComment intégrer la médecine moderne et traditionnelle ?\nQuels médicaments sont couramment prescrits ?\nComment les traitements varient-ils selon l'île ?",
"url": "https://questionsmedicales.fr/mesh/D044468?mesh_terms=Cognitive+Dysfunction&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hawaïen autochtone ou autre insulaire du Pacifique",
"description": "Quelles complications sont fréquentes chez ces populations ?\nComment les complications sont-elles gérées ?\nY a-t-il des complications spécifiques aux maladies tropicales ?\nComment prévenir les complications liées au diabète ?\nLes complications psychologiques sont-elles courantes ?",
"url": "https://questionsmedicales.fr/mesh/D044468?mesh_terms=Cognitive+Dysfunction&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hawaïen autochtone ou autre insulaire du Pacifique",
"description": "Quels sont les principaux facteurs de risque ?\nComment l'environnement influence-t-il la santé ?\nY a-t-il des facteurs génétiques à considérer ?\nQuel impact a le mode de vie sur la santé ?\nComment les inégalités sociales affectent-elles la santé ?",
"url": "https://questionsmedicales.fr/mesh/D044468?mesh_terms=Cognitive+Dysfunction&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une maladie chez les Hawaïens autochtones ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique médical, les symptômes et des tests spécifiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont recommandés pour les insulaires du Pacifique ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins, d'imagerie et des évaluations génétiques peuvent être nécessaires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des particularités dans le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des facteurs culturels et environnementaux peuvent influencer le diagnostic."
}
},
{
"@type": "Question",
"name": "Comment évaluer les risques de maladies spécifiques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une évaluation des antécédents familiaux et des facteurs environnementaux est cruciale."
}
},
{
"@type": "Question",
"name": "Les maladies génétiques sont-elles plus fréquentes ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies génétiques peuvent être plus fréquentes dans ces populations."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont courants chez les Hawaïens autochtones ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes varient, mais incluent souvent des problèmes respiratoires et métaboliques."
}
},
{
"@type": "Question",
"name": "Comment les symptômes diffèrent-ils selon les îles ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent varier en fonction des différences environnementales et génétiques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques aux maladies tropicales ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme la fièvre, les éruptions cutanées et la fatigue sont fréquents."
}
},
{
"@type": "Question",
"name": "Les symptômes psychologiques sont-ils fréquents ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes de stress et d'anxiété peuvent être plus présents dans ces populations."
}
},
{
"@type": "Question",
"name": "Comment les symptômes sont-ils perçus culturellement ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "La perception des symptômes peut être influencée par des croyances culturelles et traditionnelles."
}
},
{
"@type": "Question",
"name": "Quelles sont les stratégies de prévention pour ces populations ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des programmes de sensibilisation et d'éducation sur la santé sont essentiels."
}
},
{
"@type": "Question",
"name": "Comment promouvoir un mode de vie sain ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Encourager l'activité physique, une alimentation équilibrée et des examens réguliers."
}
},
{
"@type": "Question",
"name": "Y a-t-il des campagnes de vaccination spécifiques ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des campagnes ciblées pour des maladies comme l'hépatite B sont mises en place."
}
},
{
"@type": "Question",
"name": "Comment réduire les risques de maladies chroniques ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Promouvoir des dépistages réguliers et des interventions précoces est crucial."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'éducation communautaire ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'éducation communautaire aide à sensibiliser et à mobiliser les ressources locales."
}
},
{
"@type": "Question",
"name": "Quels traitements sont adaptés aux Hawaïens autochtones ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements doivent être personnalisés, tenant compte des spécificités culturelles et médicales."
}
},
{
"@type": "Question",
"name": "Y a-t-il des remèdes traditionnels utilisés ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des remèdes à base de plantes et des pratiques traditionnelles sont souvent utilisés."
}
},
{
"@type": "Question",
"name": "Comment intégrer la médecine moderne et traditionnelle ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une approche intégrative peut améliorer l'adhésion au traitement et le bien-être global."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont couramment prescrits ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les médicaments pour les maladies chroniques comme le diabète et l'hypertension sont fréquents."
}
},
{
"@type": "Question",
"name": "Comment les traitements varient-ils selon l'île ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements peuvent varier en fonction de l'accès aux soins et des ressources disponibles."
}
},
{
"@type": "Question",
"name": "Quelles complications sont fréquentes chez ces populations ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des maladies cardiovasculaires et des troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles gérées ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion implique un suivi régulier et des ajustements de traitement appropriés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications spécifiques aux maladies tropicales ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications comme la dengue et le chikungunya peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications liées au diabète ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un contrôle glycémique rigoureux et des soins des pieds sont essentiels."
}
},
{
"@type": "Question",
"name": "Les complications psychologiques sont-elles courantes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications comme la dépression peuvent être fréquentes dans ces populations."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'obésité, le tabagisme et l'accès limité aux soins de santé."
}
},
{
"@type": "Question",
"name": "Comment l'environnement influence-t-il la santé ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs environnementaux comme la pollution et l'accès à l'eau potable jouent un rôle."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs génétiques à considérer ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des prédispositions génétiques à certaines maladies sont observées dans ces populations."
}
},
{
"@type": "Question",
"name": "Quel impact a le mode de vie sur la santé ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sédentaire et une mauvaise alimentation augmentent les risques de maladies."
}
},
{
"@type": "Question",
"name": "Comment les inégalités sociales affectent-elles la santé ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les inégalités d'accès aux soins et à l'éducation aggravent les problèmes de santé."
}
}
]
}
]
}
Cognitive dysfunction is part of the broad spectrum of clinical manifestations in older untreated hereditary transthyretin amyloidosis patients with peripheral polyneuropathy....
The objective of this study is to systematically explore cognitive dysfunction in ATTRV30M amyloidosis patients whose disease course was modified by liver transplant (LT)....
A series of 269 carriers of TTRVal30Met mutation treated with LT underwent a neuropsychological assessment. Clinical charts were reviewed to identify focal neurological episodes (FNEs), cognitive comp...
Cognitive dysfunction was identified in 35 patients (13%)-14 (5%) had mild and 21 (8%) had moderate dysfunction. In comparison to normal cognition, both mild and moderate cognitive dysfunction patient...
Consistent with the natural history of the disease, older age and higher severity of the disease are significantly associated and potentially predictors of cognitive dysfunction in ATTRV30M patients t...
The impact of cardiovascular diseases on cognition raises important research questions. The study aimed to investigate the relationship between demographic data, cardiovascular diseases, kidney diseas...
A cross-sectional study of patients with cardiovascular diseases was performed. The Montreal Cognitive Assessment (MoCA) was applied for cognitive evaluation. Based on MoCA three groups were defined: ...
Of 628 patients, 55.2% had mild CD, and the mean age was 67.95 (SD 9.53) years. Cα and Mω were 0.7, indicating good internal consistency. We found a moderate positive correlation between depression an...
Mild CD was the most common in patients with cardiovascular diseases. Older age, lower education, being a non-smoker, and renal dysfunction were risk factors for both mild and advanced CD. Female gend...
Stroke survivors not only suffer from severe motor, speech and neurocognitive deficits, but in many cases also from a "lack of pleasure" and a reduced motivational level. Especially apathy and anhedon...
(a) To characterize the frequency of objective cognitive deficits and self-perceived cognitive difficulties and (b) to explore demographic and clinical predictors of cognitive dysfunction and cognitiv...
One hundred and ten adults diagnosed with COVID-19 between March and November 2020, aged ≤ 74 years underwent a brief neuropsychological evaluation 12 months after infection, which included: Brief Vis...
Twenty participants (18.2%) had cognitive dysfunction and 36 (33.3%) had cognitive complaints. Cognitive dysfunction was related to lower education, preinfection history of headache/migraine, and acut...
A subset of individuals develops cognitive difficulties in the context of post-COVID syndrome. Results may support the protective effect of education, a known proxy of cognitive reserve. COVID-19 infe...
During the last years, a growing number of studies have investigated the link between cognitive dysfunction and rheumatoid arthritis (RA), highlighting the potential pathogenic role of several clinica...
We performed a systematic review using PRISMA (Preferred Reported Items for Systematic Reviews and Meta-analysis) protocol. A systematic search was conducted in the PubMed/MEDLINE, EMBASE, LILACS, Sco...
Five original studies were included, which provided data from 428 participants. Among plasma proteins, SHH was increased and TTR was reduced in patients with mild cognitive impairment; anti-myelin bas...
Despite the relative scarcity of studies on this subject and the heterogeneity of results, we identified possible biomarkers for cognitive deficits in the RA population. Further longitudinal studies a...
Toll-like receptors (TLRs) are pattern recognition receptors (PRRs) with a well-documented role in the innate and adaptive immune responses. Interestingly, TLR activation has also been linked to sever...
The origin of pre-existing cognitive impairment in stroke patients remains controversial, with a vascular or a degenerative hypothesis....
To determine whether endothelial dysfunction is associated with pre-existing cognitive problems, lesion load and biological anomalies in stroke patients....
Patients originated from the prospective STROKDEM study. The baseline cognitive state, assessed using the IQ-CODE, and risk factors for stroke were recorded at inclusion. Patients with an IQ-CODE scor...
A total of 86 patients were included (52 males; mean age 63.5 ± 11.5 years). Patients with abnormal RHI have hypertension or antihypertensive treatment more often. The baseline IQ-CODE was abnormal in...
A vascular mechanism may be responsible for cognitive problems pre-existing stroke. The measurement of endothelial dysfunction after stroke could become an important element of follow-up, providing an...
There is increasing recognition of the prevalence and impact of cognitive dysfunction (CD) in heart failure (HF) patients. This contemporary review appraises the evidence for epidemiological associati...
CD disproportionately affects heart failure patients, even accounting for known comorbid risk factors, and this may extend to subclinical left ventricular dysfunction. Neuroimaging studies now provide...
Cognitive dysfunction is increasingly recognized as a complication and comorbidity of diabetes, supported by evidence of abnormal brain structure and function. Although few mechanistic metabolic studi...
There is limited data on cognition in patients undergoing peritoneal dialysis (PD). We assessed prevalence and associated risk factors of neurocognitive impairment (NCI) in PD patients....
A cross-sectional cohort study of 149 PD patients at a single centre between 2016 and 2020 who underwent neurocognitive screening at defined intervals by Addenbrooke's Cognitive Examination - Revised ...
Patients on PD performed poorly in ACE-R screening compared to population norms, with discrepancy in all cognitive domains. In patients without CVD, attention and language domains were comparable to n...
Patients on PD have higher prevalence of NCI than the general population, primarily with impairments in memory, fluency and visuospatial reasoning. CVD confers poorer performance in attention and lang...